Clostridium difficile

Clostridium difficile is one of the HCAI’s that is closely monitored at the RNOH. In collaboration with the pharmacy department the RNOH continues to promote best practice in antimicrobial stewardship and maintains a high level of infection prevention and control measures for all HCAIs.

Use of broad-spectrum antimicrobials is monitored and restricted by using narrower spectrum agents in order to reduce the likelihood of the emergence of resistant organisms and diarrhoea associated with Clostridium difficile.

*We use this information to make improvements to our website and appreciate any feedback you can offer. Comments are emailed to the Communications Team at RNOH. The personal information collected is only used for email replies (Name and Email) and is stored encrypted in our database for 30 days and then permanently deleted.